Stay updated with breaking news from Michael Brenner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Fitzpatrick family allege they were subjected to intimidation and bullying at one of NSW’s leading trauma hospitals after the death of their beloved brother and son.
Two recent articles have recently appeared in the Russian journal Strategic Culture that point to significant changes that are occurring among western nations toward Russia and China. These changes have been in the wind for some time but in recent months the tempo has accelerated. Both Russia and China are pointing the way to a […]
From Liz Cheney's outspokeness, to Mother's Day, banning smoking, and racial equality, here are some of our top columns you may have missed.
showcasing some of Harvard’s stellar graduates. Nelson LaMarche arrived at immunology in an unexpected way. Growing up in New Jersey, he said, he idolized his Dominican physician father and wanted to become a doctor. So, LaMarche, who received his Ph.D. from Harvard Graduate School of Arts and Sciences in November 2020, attended an honors high school with a specialized premed curriculum, where he studied anatomy and physiology, did rotations with clinicians, and became an EMT, which he continued to work at throughout college. “If you had met me in college, you would not have thought ther...
Published: Apr 21, 2021 - Backed by leading healthcare investors including SV Health Investors - Cambridge, UK, 20 April 2021 – Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced its launch with $11 million seed financing from healthcare investors SV Health Investors and Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”). The Company’s mission is to develop new medicines for patients by targeting activated fibroblast populations and their role in influencing immune effector cells in disease. Powerful new technolog...